BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grady WM, Willis J, Guilford PJ, Dunbier AK, Toro TT, Lynch H, Wiesner G, Ferguson K, Eng C, Park JG. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000;26:16-17. [PMID: 10973239 DOI: 10.1038/79120] [Cited by in Crossref: 325] [Cited by in F6Publishing: 350] [Article Influence: 14.1] [Reference Citation Analysis]
Number Citing Articles
1 Kole C, Charalampakis N, Sakellariou S, Papaxoinis G, Apostolou KG, Machairas N, Papanikolaou IS, Schizas D. Hereditary Diffuse Gastric Cancer: A 2022 Update. J Pers Med 2022;12. [PMID: 36556253 DOI: 10.3390/jpm12122032] [Reference Citation Analysis]
2 Malpeli G, Barbi S, Innamorati G, Alloggio M, Filippini F, Decimo I, Castelli C, Perris R, Bencivenga M. Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer. J Pers Med 2022;12. [PMID: 36556227 DOI: 10.3390/jpm12122006] [Reference Citation Analysis]
3 Krimpenfort RA, Behr FM, Nieuwland M, Rink ID, Kerkhoven R, Lindern MV, Nethe M. E-Cadherin Expression Distinguishes Mouse from Human Hematopoiesis in the Basophil and Erythroid Lineages. Biomolecules 2022;12:1706. [DOI: 10.3390/biom12111706] [Reference Citation Analysis]
4 Cosma LS, Schlosser S, Tews HC, Müller M, Kandulski A. Hereditary Diffuse Gastric Cancer: Molecular Genetics, Biological Mechanisms and Current Therapeutic Approaches. Int J Mol Sci 2022;23:7821. [PMID: 35887173 DOI: 10.3390/ijms23147821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Carneiro F. Familial and hereditary gastric cancer, an overview. Best Pract Res Clin Gastroenterol 2022;58-59:101800. [PMID: 35988963 DOI: 10.1016/j.bpg.2022.101800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Monster JL, Kemp LJS, Gloerich M, van der Post RS. Diffuse gastric cancer: Emerging mechanisms of tumor initiation and progression. Biochim Biophys Acta Rev Cancer 2022;:188719. [PMID: 35307354 DOI: 10.1016/j.bbcan.2022.188719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Vaiphei K. Morphological Aspect of Gastric Carcinomas. Interpretation of Endoscopic Biopsy - Gastritis, Gastropathies and Beyond 2022. [DOI: 10.1007/978-981-16-6026-9_15] [Reference Citation Analysis]
8 Decourtye-Espiard L, Bougen-Zhukov N, Godwin T, Brew T, Schulpen E, Black MA, Guilford P. E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors. Cancers (Basel) 2021;14:175. [PMID: 35008338 DOI: 10.3390/cancers14010175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Choi JM, Kim SG. Effect of Helicobacter pylori Eradication on Epigenetic Changes in Gastric Cancer-related Genes. Korean J Helicobacter Up Gastrointest Res 2021;21:256-66. [DOI: 10.7704/kjhugr.2021.0042] [Reference Citation Analysis]
10 Garcia-Pelaez J, Barbosa-Matos R, São José C, Sousa S, Gullo I, Hoogerbrugge N, Carneiro F, Oliveira C. Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes. Eur J Med Genet 2022;65:104401. [PMID: 34871783 DOI: 10.1016/j.ejmg.2021.104401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Rubtsova SN, Zhitnyak IY, Gloushankova NA. Dual role of E-cadherin in cancer cells. Tissue Barriers 2021;:2005420. [PMID: 34821540 DOI: 10.1080/21688370.2021.2005420] [Reference Citation Analysis]
12 Businello G, Angerilli V, Parente P, Realdon S, Savarino E, Farinati F, Grillo F, Vanoli A, Galuppini F, Paccagnella S, Pennelli G, Mastracci L, Saragoni L, Fassan M. Molecular Landscapes of Gastric Pre-Neoplastic and Pre-Invasive Lesions. Int J Mol Sci 2021;22:9950. [PMID: 34576114 DOI: 10.3390/ijms22189950] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Zhao H, Hu H, Chen B, Xu W, Zhao J, Huang C, Xing Y, Lv H, Nie C, Wang J, He Y, Wang SQ, Chen XB. Overview on the Role of E-Cadherin in Gastric Cancer: Dysregulation and Clinical Implications. Front Mol Biosci 2021;8:689139. [PMID: 34422902 DOI: 10.3389/fmolb.2021.689139] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
14 Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet 2021:S0168-9525(21)00130-X. [PMID: 34120771 DOI: 10.1016/j.tig.2021.05.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 63] [Article Influence: 22.0] [Reference Citation Analysis]
15 Tedaldi G, Molinari C, São José C, Barbosa-Matos R, André A, Danesi R, Arcangeli V, Ravegnani M, Saragoni L, Morgagni P, Rebuzzi F, Canale M, Pignatta S, Ferracci E, Martinelli G, Ranzani GN, Oliveira C, Calistri D, Ulivi P. Genetic and Epigenetic Alterations of CDH1 Regulatory Regions in Hereditary and Sporadic Gastric Cancer. Pharmaceuticals (Basel) 2021;14:457. [PMID: 34066170 DOI: 10.3390/ph14050457] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Gamble LA, Heller T, Davis JL. Hereditary Diffuse Gastric Cancer Syndrome and the Role of CDH1: A Review. JAMA Surg 2021;156:387-92. [PMID: 33404644 DOI: 10.1001/jamasurg.2020.6155] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
17 Grady WM. Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer. Adv Cancer Res 2021;151:425-68. [PMID: 34148620 DOI: 10.1016/bs.acr.2021.02.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
18 Grady WM, Yu M, Markowitz SD. Epigenetic Alterations in the Gastrointestinal Tract: Current and Emerging Use for Biomarkers of Cancer. Gastroenterology 2021;160:690-709. [PMID: 33279516 DOI: 10.1053/j.gastro.2020.09.058] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 26.5] [Reference Citation Analysis]
19 Singh J, Kumar P, Verma K, Tiwary SK, Narayan G, Dixit VK. Molecular genetic changes in gastric carcinoma. IJMIO 2021;6:30-46. [DOI: 10.25259/ijmio_8_2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Gullo I, Oliveira C, van der Post RS, van Dieren JM, Davis JL, Bougen-zhukov N, Guilford P, Carneiro F. Updated perspective and directions on hereditary diffuse gastric cancer. Research and Clinical Applications of Targeting Gastric Neoplasms 2021. [DOI: 10.1016/b978-0-323-85563-1.00011-3] [Reference Citation Analysis]
21 Zhao L, Wu X, Zheng J, Dong D. DNA methylome profiling of circulating tumor cells in lung cancer at single base-pair resolution. Oncogene 2021;40:1884-95. [PMID: 33564067 DOI: 10.1038/s41388-021-01657-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
22 Iyer P, Moslim M, Farma JM, Denlinger CS. Diffuse gastric cancer: histologic, molecular, and genetic basis of disease. Transl Gastroenterol Hepatol 2020;5:52. [PMID: 33073047 DOI: 10.21037/tgh.2020.01.02] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
23 Goud HK, Mehkari Z, Mohammed L, Javed M, Althwanay A, Ahsan F, Oliveri F, Rutkofsky IH. Significance of E-cadherin Gene Mutations in Patients With Hereditary Diffuse Gastric Cancer Syndrome: A Systematic Review. Cureus 2020;12:e10406. [PMID: 33062523 DOI: 10.7759/cureus.10406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
24 Hu MN, Hu SH, Zhang XW, Xiong SM, Deng H. Overview on new progress of hereditary diffuse gastric cancer with CDH1 variants. Tumori 2020;106:346-55. [PMID: 32811340 DOI: 10.1177/0300891620949668] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Casalino L, Verde P. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis. Genes (Basel) 2020;11:E922. [PMID: 32806509 DOI: 10.3390/genes11080922] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
26 Zhou Y, Cheng X, Zhang F, Chen Q, Chen X, Shen Y, Lai C, Kota VG, Sun W, Huang Q, Yuan Y, Wang J, Lai M, Zhang D. Integrated multi-omics data analyses for exploring the co-occurring and mutually exclusive gene alteration events in colorectal cancer. Hum Mutat 2020;41:1588-99. [PMID: 32485022 DOI: 10.1002/humu.24059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Niemeyer E, Mofid H, Zornig C, Burandt EC, Stein A, Block A, Volk AE. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family. BMC Gastroenterol 2020;20:129. [PMID: 32362280 DOI: 10.1186/s12876-020-01283-2] [Reference Citation Analysis]
28 Bresalier RS, Grady WM, Markowitz SD, Nielsen HJ, Batra SK, Lampe PD. Biomarkers for Early Detection of Colorectal Cancer: The Early Detection Research Network, a Framework for Clinical Translation. Cancer Epidemiol Biomarkers Prev 2020;29:2431-40. [PMID: 32299850 DOI: 10.1158/1055-9965.EPI-20-0234] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
29 Selvanathan A, Nixon CY, Zhu Y, Scietti L, Forneris F, Uribe LMM, Lidral AC, Jezewski PA, Mulliken JB, Murray JC, Buckley MF, Cox TC, Roscioli T. CDH1 Mutation Distribution and Type Suggests Genetic Differences between the Etiology of Orofacial Clefting and Gastric Cancer. Genes (Basel) 2020;11:E391. [PMID: 32260281 DOI: 10.3390/genes11040391] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
30 Renaud F, Svrcek M. [Hereditary gastric cancer: Challenges for the pathologist in 2020]. Ann Pathol 2020;40:95-104. [PMID: 32147190 DOI: 10.1016/j.annpat.2020.02.007] [Reference Citation Analysis]
31 Xie W, Chen C, Han Z, Huang J, Liu X, Chen H, Zhang T, Chen S, Chen C, Lu M, Shen X, Xue X. CD2AP inhibits metastasis in gastric cancer by promoting cellular adhesion and cytoskeleton assembly. Mol Carcinog 2020;59:339-52. [PMID: 31989722 DOI: 10.1002/mc.23158] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 Shin SY, Kim JH, Chun J, Yoon YH, Park H. Chronic atrophic gastritis and intestinal metaplasia surrounding diffuse-type gastric cancer: Are they just bystanders in the process of carcinogenesis? PLoS One 2019;14:e0226427. [PMID: 31851694 DOI: 10.1371/journal.pone.0226427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
33 Shenoy S. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management. Cancer Manag Res 2019;11:10477-86. [PMID: 31853199 DOI: 10.2147/CMAR.S208818] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
34 van der Post RS, Oliveira C, Guilford P, Carneiro F. Hereditary gastric cancer: what's new? Update 2013-2018. Fam Cancer. 2019;18:363-367. [PMID: 30989426 DOI: 10.1007/s10689-019-00127-7] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
35 Xiong Y, Hu L, Zhang T, Wang M, Xu H, Li TC, Sun Y, Wang CC. Effects of high progesterone in in-vitro fertilization cycle on DNA methylation and gene expression of adhesion molecules on endometrium during implantation window. J Assist Reprod Genet 2020;37:33-43. [PMID: 31758513 DOI: 10.1007/s10815-019-01623-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
36 Feng W, Ding Y, Zong W, Ju S. Non-coding RNAs in regulating gastric cancer metastasis. Clin Chim Acta. 2019;496:125-133. [PMID: 31276633 DOI: 10.1016/j.cca.2019.07.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
37 Chen X, Li X, Liang H, Wei L, Cui Q, Yao M, Wu X. A new mutL homolog 1 c.1896+5G>A germline mutation detected in a Lynch syndrome-associated lung and gastric double primary cancer patient. Mol Genet Genomic Med 2019;7:e787. [PMID: 31207149 DOI: 10.1002/mgg3.787] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
38 Moinova HR, LaFramboise T, Lutterbaugh JD, Chandar AK, Dumot J, Faulx A, Brock W, De la Cruz Cabrera O, Guda K, Barnholtz-Sloan JS, Iyer PG, Canto MI, Wang JS, Shaheen NJ, Thota PN, Willis JE, Chak A, Markowitz SD. Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus. Sci Transl Med 2018;10:eaao5848. [PMID: 29343623 DOI: 10.1126/scitranslmed.aao5848] [Cited by in Crossref: 81] [Cited by in F6Publishing: 88] [Article Influence: 20.3] [Reference Citation Analysis]
39 Kagohara LT, Stein-O'Brien GL, Kelley D, Flam E, Wick HC, Danilova LV, Easwaran H, Favorov AV, Qian J, Gaykalova DA, Fertig EJ. Epigenetic regulation of gene expression in cancer: techniques, resources and analysis. Brief Funct Genomics 2018;17:49-63. [PMID: 28968850 DOI: 10.1093/bfgp/elx018] [Cited by in Crossref: 67] [Cited by in F6Publishing: 75] [Article Influence: 16.8] [Reference Citation Analysis]
40 Figueiredo J, Melo S, Carneiro P, Moreira AM, Fernandes MS, Ribeiro AS, Guilford P, Paredes J, Seruca R. Clinical spectrum and pleiotropic nature of CDH1 germline mutations. J Med Genet. 2019;56:199-208. [PMID: 30661051 DOI: 10.1136/jmedgenet-2018-105807] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 12.0] [Reference Citation Analysis]
41 Tang B, Tian Y, Liao Y, Li Z, Yu S, Su H, Zhong F, Yuan G, Wang Y, Yu H, Tomlinson S, Qiu X, He S. CBX8 exhibits oncogenic properties and serves as a prognostic factor in hepatocellular carcinoma. Cell Death Dis 2019;10:52. [PMID: 30718464 DOI: 10.1038/s41419-018-1288-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
42 Rotondo R, Rizzolio F, Perin T, Berretta M, Zanconati F, Giordano A, Canzonieri V. Pathological Diagnosis and Classification of Gastric Epithelial Tumours. Current Clinical Pathology 2019. [DOI: 10.1007/978-3-030-04861-7_4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Luo W, Fedda F, Lynch P, Tan D. CDH1 Gene and Hereditary Diffuse Gastric Cancer Syndrome: Molecular and Histological Alterations and Implications for Diagnosis And Treatment. Front Pharmacol. 2018;9:1421. [PMID: 30568591 DOI: 10.3389/fphar.2018.01421] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 8.4] [Reference Citation Analysis]
44 Hashimoto T, Ogawa R, Tang T, Yoshida H, Taniguchi H, Katai H, Oda I, Sekine S. RHOA mutations and CLDN18-ARHGAP fusions in intestinal-type adenocarcinoma with anastomosing glands of the stomach. Mod Pathol 2019;32:568-75. [DOI: 10.1038/s41379-018-0181-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
45 Mills JC, Samuelson LC. Past Questions and Current Understanding About Gastric Cancer. Gastroenterology 2018;155:939-44. [PMID: 29964037 DOI: 10.1053/j.gastro.2018.06.044] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
46 Ansari S, Gantuya B, Tuan VP, Yamaoka Y. Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity. Int J Mol Sci 2018;19:E2424. [PMID: 30115886 DOI: 10.3390/ijms19082424] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
47 de Castro Sant' Anna C, Junior AGF, Soares P, Tuji F, Paschoal E, Chaves LC, Burbano RR. Molecular biology as a tool for the treatment of cancer. Clin Exp Med 2018;18:457-64. [PMID: 30006681 DOI: 10.1007/s10238-018-0518-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
48 Abbas M, Faggian A, Sintali DN, Khan GJ, Naeem S, Shi M, Dingding C. Current and future biomarkers in gastric cancer. Biomedicine & Pharmacotherapy 2018;103:1688-700. [DOI: 10.1016/j.biopha.2018.04.178] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
49 van der Post RS, Carneiro F. Emerging Concepts in Gastric Neoplasia: Heritable Gastric Cancers and Polyposis Disorders. Surg Pathol Clin. 2017;10:931-945. [PMID: 29103540 DOI: 10.1016/j.path.2017.07.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
50 Spoto CP, Gullo I, Carneiro F, Montgomery EA, Brosens LA. Hereditary gastrointestinal carcinomas and their precursors: An algorithm for genetic testing. Seminars in Diagnostic Pathology 2018;35:170-83. [DOI: 10.1053/j.semdp.2018.01.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
51 Yoshii T, Miyagi Y, Nakamura Y, Kobayashi O, Kameda Y, Ohkawa S. Pilot Research for the Correlation between the Expression Pattern of E-cadherin-β-Catenin Complex and Lymph Node Metastasis in Early Gastric Cancer. Tumori 2013;99:234-8. [DOI: 10.1177/030089161309900219] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
52 Zylberberg HM, Sultan K, Rubin S. Hereditary diffuse gastric cancer: One family’s story. World J Clin Cases 2018; 6(1): 1-5 [PMID: 29376063 DOI: 10.12998/wjcc.v6.i1.1] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
53 Zhou J, Shi J, Fu X, Mao B, Wang W, Li W, Li G, Zhou S. Linc00441 interacts with DNMT1 to regulate RB1 gene methylation and expression in gastric cancer. Oncotarget 2018;9:37471-9. [PMID: 30680063 DOI: 10.18632/oncotarget.23928] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
54 Niller HH, Minarovits J. Epigenetics and Human Infectious Diseases. Epigenetics in Human Disease 2018. [DOI: 10.1016/b978-0-12-812215-0.00021-2] [Reference Citation Analysis]
55 Sepulveda AR, J. Del Portillo A. Molecular Basis of Diseases of the Gastrointestinal Tract. Molecular Pathology 2018. [DOI: 10.1016/b978-0-12-802761-5.00019-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
56 Zhi P, Shi J, Liu F. Genetic variations at 8q24 and gastric cancer susceptibility: A meta-analysis study. PLoS One 2017;12:e0188774. [PMID: 29232378 DOI: 10.1371/journal.pone.0188774] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
57 Melo S, Figueiredo J, Fernandes MS, Gonçalves M, Morais-de-Sá E, Sanches JM, Seruca R. Predicting the Functional Impact of CDH1 Missense Mutations in Hereditary Diffuse Gastric Cancer. Int J Mol Sci 2017;18:E2687. [PMID: 29231860 DOI: 10.3390/ijms18122687] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
58 Jiao F, Hu H, Han T, Zhuo M, Yuan C, Yang H, Wang L, Wang L. Aberrant expression of nuclear HDAC3 and cytoplasmic CDH1 predict a poor prognosis for patients with pancreatic cancer. Oncotarget 2016;7:16505-16. [PMID: 26918727 DOI: 10.18632/oncotarget.7663] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
59 Zhang B, Zhou J, Liu Z, Gu L, Ji J, Kim WH, Deng D. Clinical and biological significance of a - 73A > C variation in the CDH1 promoter of patients with sporadic gastric carcinoma. Gastric Cancer 2018;21:606-16. [PMID: 29168119 DOI: 10.1007/s10120-017-0778-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
60 Meng J, Wang LH, Zou CL, Dai SM, Zhang J, Lu Y. C10orf116 Gene Copy Number Loss in Prostate Cancer: Clinicopathological Correlations and Prognostic Significance. Med Sci Monit 2017;23:5176-83. [PMID: 29084195 DOI: 10.12659/msm.906680] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
61 Carlomagno N, Incollingo P, Tammaro V, Peluso G, Rupealta N, Chiacchio G, Sandoval Sotelo ML, Minieri G, Pisani A, Riccio E, Sabbatini M, Bracale UM, Calogero A, Dodaro CA, Santangelo M. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. Biomed Res Int. 2017;2017:7869802. [PMID: 29094049 DOI: 10.1155/2017/7869802] [Cited by in Crossref: 55] [Cited by in F6Publishing: 61] [Article Influence: 9.2] [Reference Citation Analysis]
62 Wu H, Hu Y, Liu X, Song W, Gong P, Zhang K, Chen Z, Zhou M, Shen X, Qian Y, Fan H. LncRNA TRERNA1 Function as an Enhancer of SNAI1 Promotes Gastric Cancer Metastasis by Regulating Epithelial-Mesenchymal Transition. Mol Ther Nucleic Acids 2017;8:291-9. [PMID: 28918030 DOI: 10.1016/j.omtn.2017.06.021] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
63 Li BQ, Liu PP, Zhang CH. Correlation between the methylation of APC gene promoter and colon cancer. Oncol Lett 2017;14:2315-9. [PMID: 28781669 DOI: 10.3892/ol.2017.6455] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
64 Alvizi L, Ke X, Brito LA, Seselgyte R, Moore GE, Stanier P, Passos-Bueno MR. Differential methylation is associated with non-syndromic cleft lip and palate and contributes to penetrance effects. Sci Rep 2017;7:2441. [PMID: 28550290 DOI: 10.1038/s41598-017-02721-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 6.8] [Reference Citation Analysis]
65 Bell JSK, Vertino PM. Orphan CpG islands define a novel class of highly active enhancers. Epigenetics 2017;12:449-64. [PMID: 28448736 DOI: 10.1080/15592294.2017.1297910] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
66 Kriangkrai R, Chareonvit S, Iseki S, Limwongse V. Pretreatment Effect of Folic Acid on 13-Cis-RA-Induced Cellular Damage of Developing Midfacial Processes in Cultured Rat Embryos. Open Dent J 2017;11:200-12. [PMID: 28567144 DOI: 10.2174/1874210601711010200] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
67 Kagohara LT, Stein-o’brien G, Kelley D, Flam E, Wick HC, Danilova LV, Easwaran H, Favorov AV, Qian J, Gaykalova DA, Fertig EJ. Epigenetic Regulation of Gene Expression in Cancer: Techniques, Resources, and Analysis.. [DOI: 10.1101/114025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
68 Manna A, Banerjee S, Khan P, Bhattacharya A, Das T. Contribution of nuclear events in generation and maintenance of cancer stem cells: revisiting chemo-resistance. Nucleus 2017;60:121-35. [DOI: 10.1007/s13237-017-0193-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
69 Sheng L, Zhang S, Xu H. Effect of Slug-Mediated Down-Regulation of E-Cadherin on Invasiveness and Metastasis of Anaplastic Thyroid Cancer Cells. Med Sci Monit 2017;23:138-43. [PMID: 28070118 DOI: 10.12659/msm.902725] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
70 Li L, Fan X. Molecular Pathology of Heredity Gastric Cancer. Personalized Management of Gastric Cancer 2017. [DOI: 10.1007/978-981-10-3978-2_1] [Reference Citation Analysis]
71 Pérez Cala T, Universidad de Antioquia. Factores genéticos y epigenéticos del cáncer gástrico. Actual Biol 2017;39:5-20. [DOI: 10.17533/udea.acbi.v39n106a01] [Reference Citation Analysis]
72 Martín-subero JI, Esteller M. Epigenetic Mechanisms in Cancer Development. The Molecular Basis of Human Cancer 2017. [DOI: 10.1007/978-1-59745-458-2_16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
73 Izaguirre MF, Casco VH. E-cadherin roles in animal biology: A perspective on thyroid hormone-influence. Cell Commun Signal 2016;14:27. [PMID: 27814736 DOI: 10.1186/s12964-016-0150-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
74 Maiuri AR, O'Hagan HM. Interplay Between Inflammation and Epigenetic Changes in Cancer. Prog Mol Biol Transl Sci 2016;144:69-117. [PMID: 27865469 DOI: 10.1016/bs.pmbts.2016.09.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
75 Baylin SB, Jones PA. Epigenetic Determinants of Cancer. Cold Spring Harb Perspect Biol 2016;8:a019505. [PMID: 27194046 DOI: 10.1101/cshperspect.a019505] [Cited by in Crossref: 545] [Cited by in F6Publishing: 594] [Article Influence: 77.9] [Reference Citation Analysis]
76 Petrova YI, Schecterson L, Gumbiner BM. Roles for E-cadherin cell surface regulation in cancer. Mol Biol Cell. 2016;27:3233-3244. [PMID: 27582386 DOI: 10.1091/mbc.e16-01-0058] [Cited by in Crossref: 140] [Cited by in F6Publishing: 153] [Article Influence: 20.0] [Reference Citation Analysis]
77 Ahmad SA, Xia BT, Bailey CE, Abbott DE, Helmink BA, Daly MC, Thota R, Schlegal C, Winer LK, Ahmad SA, Al Humaidi AH, Parikh AA. An update on gastric cancer. Curr Probl Surg 2016;53:449-90. [PMID: 27671911 DOI: 10.1067/j.cpsurg.2016.08.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
78 Baniak N, Senger JL, Ahmed S, Kanthan SC, Kanthan R. Gastric biomarkers: a global review. World J Surg Oncol. 2016;14:212. [PMID: 27514667 DOI: 10.1186/s12957-016-0969-3] [Cited by in Crossref: 67] [Cited by in F6Publishing: 72] [Article Influence: 9.6] [Reference Citation Analysis]
79 Lando M, Fjeldbo CS, Wilting SM, C Snoek B, Aarnes EK, Forsberg MF, Kristensen GB, Steenbergen RD, Lyng H. Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer. Epigenetics 2015;10:970-80. [PMID: 26291246 DOI: 10.1080/15592294.2015.1085140] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 4.9] [Reference Citation Analysis]
80 Tie J, Zhang X, Fan D. Epigenetic roles in the malignant transformation of gastric mucosal cells. Cell Mol Life Sci 2016;73:4599-610. [PMID: 27464701 DOI: 10.1007/s00018-016-2308-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
81 Tenhagen M, Klarenbeek S, Braumuller TM, Hofmann I, van der Groep P, Ter Hoeve N, van der Wall E, Jonkers J, Derksen PW. p120-Catenin Is Critical for the Development of Invasive Lobular Carcinoma in Mice. J Mammary Gland Biol Neoplasia 2016;21:81-8. [PMID: 27411687 DOI: 10.1007/s10911-016-9358-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
82 Skierucha M, Milne AN, Offerhaus GJA, Polkowski WP, Maciejewski R, Sitarz R. Molecular alterations in gastric cancer with special reference to the early-onset subtype. World J Gastroenterol 2016; 22(8): 2460-2474 [PMID: 26937134 DOI: 10.3748/wjg.v22.i8.2460] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 37] [Article Influence: 4.4] [Reference Citation Analysis]
83 Al-Ahmadie HA, Iyer G, Lee BH, Scott SN, Mehra R, Bagrodia A, Jordan EJ, Gao SP, Ramirez R, Cha EK, Desai NB, Zabor EC, Ostrovnaya I, Gopalan A, Chen YB, Fine SW, Tickoo SK, Gandhi A, Hreiki J, Viale A, Arcila ME, Dalbagni G, Rosenberg JE, Bochner BH, Bajorin DF, Berger MF, Reuter VE, Taylor BS, Solit DB. Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer. Nat Genet 2016;48:356-8. [PMID: 26901067 DOI: 10.1038/ng.3503] [Cited by in Crossref: 117] [Cited by in F6Publishing: 121] [Article Influence: 16.7] [Reference Citation Analysis]
84 Li Y, Ran R, Guan Y, Zhu X, Kang S. Aberrant Methylation of the E-Cadherin Gene Promoter Region in the Endometrium of Women With Uterine Fibroids. Reprod Sci 2016;23:1096-102. [DOI: 10.1177/1933719116630415] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
85 Cervera R, Ramos A, Lluch A, Climent J. DNA Methylation in Breast Cancer. Epigenetic Biomarkers and Diagnostics 2016. [DOI: 10.1016/b978-0-12-801899-6.00015-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
86 van der Post RS, Gullo I, Oliveira C, Tang LH, Grabsch HI, O'Donovan M, Fitzgerald RC, van Krieken H, Carneiro F. Histopathological, Molecular, and Genetic Profile of Hereditary Diffuse Gastric Cancer: Current Knowledge and Challenges for the Future. Adv Exp Med Biol 2016;908:371-91. [PMID: 27573781 DOI: 10.1007/978-3-319-41388-4_18] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 5.1] [Reference Citation Analysis]
87 Iizasa H, Ishihara S, Richardo T, Kanehiro Y, Yoshiyama H. Dysbiotic infection in the stomach. World J Gastroenterol 2015; 21(40): 11450-11457 [PMID: 26523109 DOI: 10.3748/wjg.v21.i40.11450] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
88 Pernot S, Voron T, Perkins G, Lagorce-Pages C, Berger A, Taieb J. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol 2015; 21(40): 11428-11438 [PMID: 26523107 DOI: 10.3748/wjg.v21.i40.11428] [Cited by in CrossRef: 153] [Cited by in F6Publishing: 169] [Article Influence: 19.1] [Reference Citation Analysis]
89 Setia N, Clark JW, Duda DG, Hong TS, Kwak EL, Mullen JT, Lauwers GY. Familial Gastric Cancers. Oncologist. 2015;20:1365-1377. [PMID: 26424758 DOI: 10.1634/theoncologist.2015-0205] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
90 Tan RYC, Ngeow J. Hereditary diffuse gastric cancer: What the clinician should know. World J Gastrointest Oncol 2015; 7(9): 153-160 [PMID: 26380059 DOI: 10.4251/wjgo.v7.i9.153] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
91 Colvin H, Yamamoto K, Wada N, Mori M. Hereditary Gastric Cancer Syndromes. Surg Oncol Clin N Am 2015;24:765-77. [PMID: 26363540 DOI: 10.1016/j.soc.2015.06.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
92 De Falco M, Lucariello A, Iaquinto S, Esposito V, Guerra G, De Luca A. Molecular Mechanisms of Helicobacter pylori Pathogenesis. J Cell Physiol. 2015;230:1702-1707. [PMID: 25639461 DOI: 10.1002/jcp.24933] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
93 Sugimoto S, Komatsu H, Morohoshi Y, Kanai T. Recognition of and recent issues in hereditary diffuse gastric cancer. J Gastroenterol. 2015;50:831-843. [PMID: 26049741 DOI: 10.1007/s00535-015-1093-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
94 van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, Caldas C, Schreiber KE, Hardwick RH, Ausems MG, Bardram L, Benusiglio PR, Bisseling TM, Blair V, Bleiker E, Boussioutas A, Cats A, Coit D, DeGregorio L, Figueiredo J, Ford JM, Heijkoop E, Hermens R, Humar B, Kaurah P, Keller G, Lai J, Ligtenberg MJ, O'Donovan M, Oliveira C, Pinheiro H, Ragunath K, Rasenberg E, Richardson S, Roviello F, Schackert H, Seruca R, Taylor A, Ter Huurne A, Tischkowitz M, Joe ST, van Dijck B, van Grieken NC, van Hillegersberg R, van Sandick JW, Vehof R, van Krieken JH, Fitzgerald RC. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015;52:361-374. [PMID: 25979631 DOI: 10.1136/jmedgenet-2015-103094] [Cited by in Crossref: 365] [Cited by in F6Publishing: 387] [Article Influence: 45.6] [Reference Citation Analysis]
95 Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. Familial gastric cancer: genetic susceptibility, pathology, and implications for management. Lancet Oncol. 2015;16:e60-e70. [PMID: 25638682 DOI: 10.1016/s1470-2045(14)71016-2] [Cited by in Crossref: 219] [Cited by in F6Publishing: 173] [Article Influence: 27.4] [Reference Citation Analysis]
96 Martín-subero JI, Esteller M. Epigenomic code. Systems Biology of Cancer 2015. [DOI: 10.1017/cbo9780511979811.009] [Reference Citation Analysis]
97 Events responsible for aberrant genetic and epigenetic codes in cancer. Systems Biology of Cancer 2015. [DOI: 10.1017/cbo9780511979811.008] [Reference Citation Analysis]
98 Zhao Y, Feng F, Zhou YN. Stem cells in gastric cancer. World J Gastroenterol 2015; 21(1): 112-123 [PMID: 25574084 DOI: 10.3748/wjg.v21.i1.112] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
99 Ketner EP, Chu QD, Karpeh MS, Khushalani NI. Gastric Cancer. Surgical Oncology 2015. [DOI: 10.1007/978-1-4939-1423-4_9] [Reference Citation Analysis]
100 Pattison S, Boussioutas A. Pathophysiology of Hereditary Diffuse Gastric Cancer. Gastric Cancer 2015. [DOI: 10.1007/978-3-319-15826-6_6] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
101 Carcas LP. Gastric cancer review. J Carcinog. 2014;13:14. [PMID: 25589897 DOI: 10.4103/1477-3163.146506] [Cited by in Crossref: 136] [Cited by in F6Publishing: 157] [Article Influence: 15.1] [Reference Citation Analysis]
102 Pinheiro H, Oliveira C, Seruca R, Carneiro F. Hereditary diffuse gastric cancer - pathophysiology and clinical management. Best Pract Res Clin Gastroenterol 2014;28:1055-68. [PMID: 25439071 DOI: 10.1016/j.bpg.2014.09.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
103 McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol 2014;11:664-74. [PMID: 25134511 DOI: 10.1038/nrgastro.2014.143] [Cited by in Crossref: 250] [Cited by in F6Publishing: 271] [Article Influence: 27.8] [Reference Citation Analysis]
104 Shi J, Qu YP, Hou P. Pathogenetic mechanisms in gastric cancer. World J Gastroenterol 2014; 20(38): 13804-13819 [PMID: 25320518 DOI: 10.3748/wjg.v20.i38.13804] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 69] [Article Influence: 7.0] [Reference Citation Analysis]
105 Zhang B, Xing X, Li J, Lowdon RF, Zhou Y, Lin N, Zhang B, Sundaram V, Chiappinelli KB, Hagemann IS, Mutch DG, Goodfellow PJ, Wang T. Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers. BMC Genomics 2014;15:868. [PMID: 25286960 DOI: 10.1186/1471-2164-15-868] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 4.9] [Reference Citation Analysis]
106 Lee DG, Kim HS, Lee YS, Kim S, Cha SY, Ota I, Kim NH, Cha YH, Yang DH, Lee Y. Helicobacter pylori CagA promotes Snail-mediated epithelial-mesenchymal transition by reducing GSK-3 activity. Nat Commun. 2014;5:4423. [PMID: 25055241 DOI: 10.1038/ncomms5423] [Cited by in Crossref: 58] [Cited by in F6Publishing: 63] [Article Influence: 6.4] [Reference Citation Analysis]
107 Liu Z, Zhang J, Gao Y, Pei L, Zhou J, Gu L, Zhang L, Zhu B, Hattori N, Ji J, Yuasa Y, Kim W, Ushijima T, Shi H, Deng D. Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis. Clin Cancer Res. 2014;20:4598-4612. [PMID: 25009298 DOI: 10.1158/1078-0432.ccr-13-3380] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 6.9] [Reference Citation Analysis]
108 Krohn A, Ahrens T, Yalcin A, Plönes T, Wehrle J, Taromi S, Wollner S, Follo M, Brabletz T, Mani SA, Claus R, Hackanson B, Burger M. Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes. PLoS One 2014;9:e100249. [PMID: 24959847 DOI: 10.1371/journal.pone.0100249] [Cited by in Crossref: 38] [Cited by in F6Publishing: 44] [Article Influence: 4.2] [Reference Citation Analysis]
109 Carneiro F, Wen X, Seruca R, Oliveira C. Familial gastric carcinoma. Diagnostic Histopathology 2014;20:239-46. [DOI: 10.1016/j.mpdhp.2014.03.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
110 Doolittle JM, Webster-Cyriaque J. Polymicrobial infection and bacterium-mediated epigenetic modification of DNA tumor viruses contribute to pathogenesis. MBio. 2014;5:e01015-e01014. [PMID: 24781742 DOI: 10.1128/mbio.01015-14] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
111 Nickel A, Stadler SC. Role of epigenetic mechanisms in epithelial-to-mesenchymal transition of breast cancer cells. Transl Res. 2014;Apr 12; Epub ahead of print. [PMID: 24768944 DOI: 10.1016/j.trsl.2014.04.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
112 Roy DM, Walsh LA, Chan TA. Driver mutations of cancer epigenomes. Protein Cell 2014;5:265-96. [PMID: 24622842 DOI: 10.1007/s13238-014-0031-6] [Cited by in Crossref: 101] [Cited by in F6Publishing: 90] [Article Influence: 11.2] [Reference Citation Analysis]
113 Lauwers GY, Mullen JT, Chelcun Schreiber KE, Chung DC. Familial Gastric Cancers. Pathology Case Reviews 2014;19:66-73. [DOI: 10.1097/pcr.0000000000000030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
114 Banerjee J, Mishra R, Li X, Jackson RS 2nd, Sharma A, Bhowmick NA. A reciprocal role of prostate cancer on stromal DNA damage. Oncogene 2014;33:4924-31. [PMID: 24141771 DOI: 10.1038/onc.2013.431] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
115 Carneiro P, Figueiredo J, Bordeira-Carriço R, Fernandes MS, Carvalho J, Oliveira C, Seruca R. Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. Expert Opin Ther Targets 2013;17:1187-201. [PMID: 23957294 DOI: 10.1517/14728222.2013.827174] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
116 Gopal G, Raja UM, Shirley S, Rajalekshmi KR, Rajkumar T. SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer. Cancer Genet 2013;206:174-82. [PMID: 23830730 DOI: 10.1016/j.cancergen.2013.04.005] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
117 Carneiro F. Hereditary gastric cancer. Pathologe. 2012;33 Suppl 2:231-234. [PMID: 23052347 DOI: 10.1007/s00292-012-1677-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
118 Chiariotti L, Angrisano T, Keller S, Florio E, Affinito O, Pallante P, Perrino C, Pero R, Lembo F. Epigenetic modifications induced by Helicobacter pylori infection through a direct microbe–gastric epithelial cells cross-talk. Med Microbiol Immunol 2013;202:327-37. [DOI: 10.1007/s00430-013-0301-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
119 Qu Y, Dang S, Hou P. Gene methylation in gastric cancer. Clin Chim Acta. 2013;424:53-65. [PMID: 23669186 DOI: 10.1016/j.cca.2013.05.002] [Cited by in Crossref: 228] [Cited by in F6Publishing: 211] [Article Influence: 22.8] [Reference Citation Analysis]
120 Majewski IJ, Kluijt I, Cats A, Scerri TS, de Jong D, Kluin RJ, Hansford S, Hogervorst FB, Bosma AJ, Hofland I. An α-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer. J Pathol. 2013;229:621-629. [PMID: 23208944 DOI: 10.1002/path.4152] [Cited by in Crossref: 138] [Cited by in F6Publishing: 145] [Article Influence: 13.8] [Reference Citation Analysis]
121 Nadauld LD, Ford JM. Molecular profiling of gastric cancer: toward personalized cancer medicine. J Clin Oncol. 2013;31:838-839. [PMID: 23341521 DOI: 10.1200/jco.2012.47.1714] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
122 Corso G, Carvalho J, Marrelli D, Vindigni C, Carvalho B, Seruca R, Roviello F, Oliveira C. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer. J Clin Oncol. 2013;31:868-875. [PMID: 23341533 DOI: 10.1200/jco.2012.44.4612] [Cited by in Crossref: 123] [Cited by in F6Publishing: 134] [Article Influence: 12.3] [Reference Citation Analysis]
123 Carvalho J, Pinheiro H, Oliveira C. E-Cadherin Germline Mutations. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
124 Guilford P, Humar B. Molecular Mechanisms of Hereditary Diffuse Gastric Cancer Initiation and Progression. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_6] [Reference Citation Analysis]
125 Odegaard JI, Schrijver I. Molecular Pathology of Hereditary Diffuse Gastric Cancer. JCT 2013;04:554-561. [DOI: 10.4236/jct.2013.42070] [Reference Citation Analysis]
126 Carneiro F, Oliveira C, Seruca R. Hereditary Diffuse Gastric Cancer and Other Gastric Cancers Associated with Hereditary Predisposition Syndromes. Molecular Pathology Library 2013. [DOI: 10.1007/978-1-4614-6015-2_6] [Reference Citation Analysis]
127 Carneiro F. Pathology of Hereditary Gastric Cancer. Spotlight on Familial and Hereditary Gastric Cancer 2013. [DOI: 10.1007/978-94-007-6570-2_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
128 Oliveira C, Pinheiro H, Figueiredo J, Seruca R, Carneiro F. E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer. Prog Mol Biol Transl Sci 2013;116:337-59. [PMID: 23481202 DOI: 10.1016/B978-0-12-394311-8.00015-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
129 Lin Y, Lee Y, Li L, Cheng C, Yang R. Tumor suppressor SCUBE2 inhibits breast-cancer cell migration and invasion through the reversal of epithelial-mesenchymal transition. Journal of Cell Science. [DOI: 10.1242/jcs.132779] [Cited by in Crossref: 36] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
130 Carneiro F, Lauwers GY. Epithelial Tumours of the Stomach. Morson and Dawson's Gastrointestinal Pathology 2012. [DOI: 10.1002/9781118399668.ch13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
131 Piazzi G, Bazzoli F, Ricciardiello L. Epigenetic silencing of Notch signaling in gastrointestinal cancers. Cell Cycle 2012;11:4323-7. [PMID: 23085543 DOI: 10.4161/cc.22388] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
132 Wang Y, Shang Y. Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis. Exp Cell Res 2013;319:160-9. [PMID: 22935683 DOI: 10.1016/j.yexcr.2012.07.019] [Cited by in Crossref: 93] [Cited by in F6Publishing: 80] [Article Influence: 8.5] [Reference Citation Analysis]
133 Carneiro P, Fernandes MS, Figueiredo J, Caldeira J, Carvalho J, Pinheiro H, Leite M, Melo S, Oliveira P, Simões-Correia J, Oliveira MJ, Carneiro F, Figueiredo C, Paredes J, Oliveira C, Seruca R. E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions. FEBS Lett 2012;586:2981-9. [PMID: 22841718 DOI: 10.1016/j.febslet.2012.07.045] [Cited by in Crossref: 64] [Cited by in F6Publishing: 72] [Article Influence: 5.8] [Reference Citation Analysis]
134 Carvalho J, van Grieken NC, Pereira PM, Sousa S, Tijssen M, Buffart TE, Diosdado B, Grabsch H, Santos MA, Meijer G, Seruca R, Carvalho B, Oliveira C. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J Pathol. 2012;228:31-44. [PMID: 22450781 DOI: 10.1002/path.4032] [Cited by in Crossref: 33] [Cited by in F6Publishing: 84] [Article Influence: 3.0] [Reference Citation Analysis]
135 Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS, Caldeira J, Costa AM, Sim窄es-Correia J, Oliveira MJ. Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta. 2012;1826:297-311. [PMID: 22613680 DOI: 10.1016/j.bbcan.2012.05.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 101] [Article Influence: 4.0] [Reference Citation Analysis]
136 Brooks GA, Enzinger PC, Fuchs CS. Adjuvant therapy for gastric cancer: revisiting the past to clarify the future. J Clin Oncol. 2012;30:2297-2299. [PMID: 22585690 DOI: 10.1200/jco.2012.42.4069] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
137 Hoffman AM, Cairns P. Epigenetics of kidney cancer and bladder cancer. Epigenomics 2011;3:19-34. [PMID: 22126150 DOI: 10.2217/epi.10.64] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
138 Chen Y, Lee SF, Blanc E, Reuter C, Wertheim B, Martinez-Diaz P, Hoffmann AA, Partridge L. Genome-wide transcription analysis of clinal genetic variation in Drosophila. PLoS One 2012;7:e34620. [PMID: 22514645 DOI: 10.1371/journal.pone.0034620] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
139 D'Costa ZJ, Leong CM, Shields J, Matthews C, Hibma MH. Screening of drugs to counteract human papillomavirus 16 E6 repression of E-cadherin expression. Invest New Drugs 2012;30:2236-51. [PMID: 22359217 DOI: 10.1007/s10637-012-9803-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
140 Amos-Landgraf JM, Irving AA, Hartman C, Hunter A, Laube B, Chen X, Clipson L, Newton MA, Dove WF. Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms. Proc Natl Acad Sci U S A 2012;109:2060-5. [PMID: 22308460 DOI: 10.1073/pnas.1120753109] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
141 Niller HH, Minarovits J. Epigenetics and Human Infectious Diseases. Epigenetics in Human Disease. Elsevier; 2012. pp. 415-41. [DOI: 10.1016/b978-0-12-388415-2.00021-4] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
142 Vasioukhin V. Adherens junctions and cancer. Subcell Biochem 2012;60:379-414. [PMID: 22674080 DOI: 10.1007/978-94-007-4186-7_16] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
143 Kaz AM, Luo Y, Dzieciatkowski S, Chak A, Willis JE, Upton MP, Leidner RS, Grady WM. Aberrantly methylated PKP1 in the progression of Barrett's esophagus to esophageal adenocarcinoma. Genes Chromosomes Cancer. 2012;51:384-393. [PMID: 22170739 DOI: 10.1002/gcc.21923] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
144 Seevaratnam R, Coburn N, Cardoso R, Dixon M, Bocicariu A, Helyer L. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer. Gastric Cancer. 2012;15 Suppl 1:S153-S163. [PMID: 22160243 DOI: 10.1007/s10120-011-0116-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
145 Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol 2011;8:686-700. [PMID: 22009203 DOI: 10.1038/nrgastro.2011.173] [Cited by in Crossref: 432] [Cited by in F6Publishing: 466] [Article Influence: 36.0] [Reference Citation Analysis]
146 Fratta E, Sigalotti L, Covre A, Parisi G, Danielli R, Marie Nicolay HJ, Coral S, Maio M. Epigenetic Mechanisms in Cancer Formation and Progression. Cancer Epigenetics 2011. [DOI: 10.1002/9781118005743.ch10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
147 Lien Y, Wang W, Kuo L, Liu J, Wei P, Ho Y, Ting W, Wu C, Chang Y. Nicotine Promotes Cell Migration Through Alpha7 Nicotinic Acetylcholine Receptor in Gastric Cancer Cells. Ann Surg Oncol 2011;18:2671-9. [DOI: 10.1245/s10434-011-1598-2] [Cited by in Crossref: 41] [Cited by in F6Publishing: 45] [Article Influence: 3.4] [Reference Citation Analysis]
148 Milne AN, Offerhaus GJA, Carneiro F. Histopathology of familial and early-onset gastric cancer. Diagnostic Histopathology 2011;17:62-8. [DOI: 10.1016/j.mpdhp.2010.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
149 Yamamoto E, Suzuki H, Takamaru H, Yamamoto H, Toyota M, Shinomura Y. Role of DNA methylation in the development of diffuse-type gastric cancer. Digestion 2011;83:241-9. [PMID: 21273772 DOI: 10.1159/000320453] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
150 Yamashita K, Sakuramoto S, Watanabe M. Genomic and epigenetic profiles of gastric cancer: Potential diagnostic and therapeutic applications. Surg Today 2011;41:24-38. [DOI: 10.1007/s00595-010-4370-5] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
151 Walters K. Epigenetic variation. Methods Mol Biol 2011;713:185-97. [PMID: 21153620 DOI: 10.1007/978-1-60327-416-6_14] [Reference Citation Analysis]
152 Deng D, Li Q, Wang X. Methylation and demethylation of Ink4 locus in cancer development. Chin J Cancer Res 2010;22:245-252. [DOI: 10.1007/s11670-010-0245-y] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
153 Spangler B, Vardimon L, Bosserhoff AK, Kuphal S. Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma. Pigment Cell Melanoma Res 2011;24:148-64. [PMID: 20977688 DOI: 10.1111/j.1755-148X.2010.00787.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
154 Hipp S, Berg D, Ergin B, Schuster T, Hapfelmeier A, Walch A, Avril S, Schmalfeldt B, Höfler H, Becker KF. Interaction of Snail and p38 mitogen-activated protein kinase results in shorter overall survival of ovarian cancer patients. Virchows Arch. 2010;457:705-713. [PMID: 20957493 DOI: 10.1007/s00428-010-0986-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
155 Jatoi I, Benson JR, Liau SS, Chen Y, Cisco RM, Norton JA, Moley JF, Khalifeh KW, Choti MA. The role of surgery in cancer prevention. Curr Probl Surg 2010;47:750-830. [PMID: 20816140 DOI: 10.1067/j.cpsurg.2010.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
156 Kokura K, Sun L, Bedford MT, Fang J. Methyl-H3K9-binding protein MPP8 mediates E-cadherin gene silencing and promotes tumour cell motility and invasion. EMBO J. 2010;29:3673-3687. [PMID: 20871592 DOI: 10.1038/emboj.2010.239] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 6.7] [Reference Citation Analysis]
157 Hayashi A, Horiuchi A, Kikuchi N, Hayashi T, Fuseya C, Suzuki A, Konishi I, Shiozawa T. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin. Int J Cancer 2010;127:1332-46. [PMID: 20049841 DOI: 10.1002/ijc.25151] [Cited by in Crossref: 93] [Cited by in F6Publishing: 98] [Article Influence: 7.2] [Reference Citation Analysis]
158 Carneiro F, Oliveira C, Seruca R. Pathology and genetics of familial gastric cancer. Int J Surg Pathol. 2010;18:33S-36S. [PMID: 20484258 DOI: 10.1177/1066896910366463] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
159 Matsukuma KE, Mullins FM, Dietz L, Zehnder JL, Ford JM, Chun NM, Schrijver I. Hereditary diffuse gastric cancer due to a previously undescribed CDH1 splice site mutation. Human Pathology 2010;41:1200-3. [DOI: 10.1016/j.humpath.2010.01.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
160 Lee CF, Ou DS, Lee SB, Chang LH, Lin RK, Li YS, Upadhyay AK, Cheng X, Wang YC, Hsu HS, Hsiao M, Wu CW, Juan LJ. hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. J Clin Invest 2010;120:2920-30. [PMID: 20592467 DOI: 10.1172/JCI42275] [Cited by in Crossref: 77] [Cited by in F6Publishing: 80] [Article Influence: 5.9] [Reference Citation Analysis]
161 Joo JK, Kim SH, Kim HG, Kim DY, Ryu SY, Lee KH, Lee JH. CpG methylation of transcription factor 4 in gastric carcinoma. Ann Surg Oncol. 2010;17:3344-3353. [PMID: 20585880 DOI: 10.1245/s10434-010-1131-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
162 Weeks RJ, Kees UR, Song S, Morison IM. Silencing of TESTIN by dense biallelic promoter methylation is the most common molecular event in childhood acute lymphoblastic leukaemia. Mol Cancer 2010;9:163. [PMID: 20573277 DOI: 10.1186/1476-4598-9-163] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
163 Park SY, Kook MC, Kim YW, Cho NY, Kim TY, Kang GH. Mixed-type gastric cancer and its association with high-frequency CpG island hypermethylation. Virchows Arch. 2010;456:625-633. [PMID: 20422213 DOI: 10.1007/s00428-010-0916-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
164 Priya TP, Kapoor VK, Krishnani N, Agrawal V, Agrawal S. Role of E-cadherin gene in gall bladder cancer and its precursor lesions. Virchows Arch. 2010;456:507-514. [PMID: 20376482 DOI: 10.1007/s00428-010-0908-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
165 Lao-Sirieix P, Caldas C, Fitzgerald RC. Genetic predisposition to gastro-oesophageal cancer. Curr Opin Genet Dev 2010;20:210-7. [PMID: 20347291 DOI: 10.1016/j.gde.2010.03.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.2] [Reference Citation Analysis]
166 Roger L, Jullien L, Gire V, Roux P. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells. J Cell Sci. 2010;123:1295-1305. [PMID: 20332115 DOI: 10.1242/jcs.061002] [Cited by in Crossref: 71] [Cited by in F6Publishing: 79] [Article Influence: 5.5] [Reference Citation Analysis]
167 Kague E, Thomazini CM, Pardini MIDCM, Carvalho FD, Leite CV, Pinheiro NA. Methylation status of CDH1 gene in samples of gastric mucous from brazilian patients with chronic gastritis infected by Helicobacter pylori. Arq Gastroenterol 2010;47:7-12. [DOI: 10.1590/s0004-28032010000100002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
168 Takada H, Wakabayashi N, Dohi O, Yasui K, Sakakura C, Mitsufuji S, Taniwaki M, Yoshikawa T. Tissue factor pathway inhibitor 2 (TFPI2) is frequently silenced by aberrant promoter hypermethylation in gastric cancer. Cancer Genet Cytogenet. 2010;197:16-24. [PMID: 20113832 DOI: 10.1016/j.cancergencyto.2009.11.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
169 Becker K, Luber B. E-cadherin. AfCS-Nature Molecule Pages. [DOI: 10.1038/mp.a003905.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
170 Karlic H, Varga F. Epigenetics and Tumorigenesis. Epigenetics and Human Health 2010. [DOI: 10.1002/9783527628384.ch15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
171 Lien W, Vasioukhin V. Loss of Cadherin-Catenin Adhesion System in Invasive Cancer Cells. Cancer Genome and Tumor Microenvironment 2010. [DOI: 10.1007/978-1-4419-0711-0_3] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
172 Pandalai PK, Yoon SS. Hereditary Diffuse Gastric Cancer. Principles of Clinical Cancer Genetics 2010. [DOI: 10.1007/978-0-387-93846-2_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
173 Kim D, Park J. Across Culture and Health Systems: Korea. Hereditary Colorectal Cancer 2010. [DOI: 10.1007/978-1-4419-6603-2_31] [Reference Citation Analysis]
174 Brena RM, Costello JF. The Role of the Epigenome in Human Cancers. Vogel and Motulsky's Human Genetics 2010. [DOI: 10.1007/978-3-540-37654-5_17] [Reference Citation Analysis]
175 Herceg Z, Boffetta P. Epigenetic Changes in Cancer: Role of Environment. Environmental Factors, Genes, and the Development of Human Cancers 2010. [DOI: 10.1007/978-1-4419-6752-7_7] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
176 Schrader K, Huntsman D. Hereditary diffuse gastric cancer. Cancer Treat Res 2010;155:33-63. [PMID: 20517687 DOI: 10.1007/978-1-4419-6033-7_3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
177 Götze S, Feldhaus V, Traska T, Wolter M, Reifenberger G, Tannapfel A, Kuhnen C, Martin D, Müller O, Sievers S. ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma. BMC Cancer 2009;9:447. [PMID: 20017917 DOI: 10.1186/1471-2407-9-447] [Cited by in Crossref: 62] [Cited by in F6Publishing: 68] [Article Influence: 4.4] [Reference Citation Analysis]
178 Pinheiro H, Bordeira-Carriço R, Seixas S, Carvalho J, Senz J, Oliveira P, Inácio P, Gusmão L, Rocha J, Huntsman D, Seruca R, Oliveira C. Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer. Hum Mol Genet 2010;19:943-52. [PMID: 19965908 DOI: 10.1093/hmg/ddp537] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 5.4] [Reference Citation Analysis]
179 Berx G, van Roy F. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol. 2009;1:a003129. [PMID: 20457567 DOI: 10.1101/cshperspect.a003129] [Cited by in Crossref: 420] [Cited by in F6Publishing: 471] [Article Influence: 30.0] [Reference Citation Analysis]
180 Yamada H, Shinmura K, Goto M, Iwaizumi M, Konno H, Kataoka H, Yamada M, Ozawa T, Tsuneyoshi T, Tanioka F, Sugimura H. Absence of germline mono-allelic promoter hypermethylation of the CDH1 gene in gastric cancer patients. Mol Cancer 2009;8:63. [PMID: 19671196 DOI: 10.1186/1476-4598-8-63] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
181 Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126:615-628. [PMID: 19657673 DOI: 10.1007/x00439-009-0722-] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
182 Milne AN, Carneiro F, O'Morain C, Offerhaus GJ. Nature meets nurture: molecular genetics of gastric cancer. Hum Genet. 2009;126:615-628. [PMID: 19657673 DOI: 10.1007/s00439-009-0722-x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 145] [Article Influence: 11.1] [Reference Citation Analysis]
183 Yoshida J, Horiuchi A, Kikuchi N, Hayashi A, Osada R, Ohira S, Shiozawa T, Konishi I. Changes in the expression of E-cadherin repressors, Snail, Slug, SIP1, and Twist, in the development and progression of ovarian carcinoma: the important role of Snail in ovarian tumorigenesis and progression. Med Mol Morphol 2009;42:82-91. [PMID: 19536615 DOI: 10.1007/s00795-008-0436-5] [Cited by in Crossref: 78] [Cited by in F6Publishing: 81] [Article Influence: 5.6] [Reference Citation Analysis]
184 Ausch C, Kim YH, Tsuchiya KD, Dzieciatkowski S, Washington MK, Paraskeva C, Radich J, Grady WM. Comparative analysis of PCR-based biomarker assay methods for colorectal polyp detection from fecal DNA. Clin Chem. 2009;55:1559-1563. [PMID: 19541867 DOI: 10.1373/clinchem.2008.122937] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 2.9] [Reference Citation Analysis]
185 Kim WJ, Kim YJ. Epigenetic biomarkers in urothelial bladder cancer. Expert Rev Mol Diagn 2009;9:259-69. [PMID: 19379084 DOI: 10.1586/erm.09.5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
186 Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carriço R, Senz J, Kaurah P, Carvalho J, Pereira R, Gusmão L, Wen X, Cipriano MA, Yokota J, Carneiro F, Huntsman D, Seruca R. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009;136:2137-48. [PMID: 19269290 DOI: 10.1053/j.gastro.2009.02.065] [Cited by in Crossref: 120] [Cited by in F6Publishing: 128] [Article Influence: 8.6] [Reference Citation Analysis]
187 Humar B, Guilford P. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci. 2009;100:1151-1157. [PMID: 19432899 DOI: 10.1111/j.1349-7006.2009.01163.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 4.7] [Reference Citation Analysis]
188 Oliveira C, Seruca R, Carneiro F. Hereditary gastric cancer. Best Pract Res Clin Gastroenterol 2009;23:147-57. [PMID: 19414142 DOI: 10.1016/j.bpg.2009.02.003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 3.6] [Reference Citation Analysis]
189 Thomas X, Chelghoum Y, Barraco F, Troncy J. The rationale and use of hypomethylation agents in adult acute myeloid leukemia. Expert Opinion on Drug Discovery 2009;4:195-205. [DOI: 10.1517/17460440802707337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
190 Jiang SW, Li J, Podratz K, Dowdy S. Application of DNA methylation biomarkers for endometrial cancer management. Expert Rev Mol Diagn 2008;8:607-16. [PMID: 18785809 DOI: 10.1586/14737159.8.5.607] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
191 Barros-Silva JD, Leitão D, Afonso L, Vieira J, Dinis-Ribeiro M, Fragoso M, Bento MJ, Santos L, Ferreira P, Rêgo S, Brandão C, Carneiro F, Lopes C, Schmitt F, Teixeira MR. Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. Br J Cancer 2009;100:487-93. [PMID: 19156142 DOI: 10.1038/sj.bjc.6604885] [Cited by in Crossref: 110] [Cited by in F6Publishing: 126] [Article Influence: 7.9] [Reference Citation Analysis]
192 Sepulveda AR, Aisner DL. Molecular Basis of Diseases of the Gastrointestinal Tract. Molecular Pathology 2009. [DOI: 10.1016/b978-0-12-374419-7.00019-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
193 Nagarajan RP, Costello JF. Epigenetic Profiling of Gliomas. CNS Cancer 2009. [DOI: 10.1007/978-1-60327-553-8_26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
194 Chan AOO, Wong BC. Deregulation of E-Cadherin in Precancerous Lesions and Gastric Cancer. The Biology of Gastric Cancers 2009. [DOI: 10.1007/978-0-387-69182-4_14] [Reference Citation Analysis]
195 Carneiro F, Oliveira C, Leite M, Seruca R. Molecular targets and biological modifiers in gastric cancer. Semin Diagn Pathol. 2008;25:274-287. [PMID: 19013893 DOI: 10.1053/j.semdp.2008.07.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
196 Barber M, Murrell A, Ito Y, Maia AT, Hyland S, Oliveira C, Save V, Carneiro F, Paterson AL, Grehan N. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer. J Pathol. 2008;216:295-306. [PMID: 18788075 DOI: 10.1002/path.2426] [Cited by in Crossref: 99] [Cited by in F6Publishing: 110] [Article Influence: 6.6] [Reference Citation Analysis]
197 Suzuki H, Tokino T, Shinomura Y, Imai K, Toyota M. DNA methylation and cancer pathways in gastrointestinal tumors. Pharmacogenomics 2008;9:1917-28. [DOI: 10.2217/14622416.9.12.1917] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.4] [Reference Citation Analysis]
198 Cisco RM, Ford JM, Norton JA. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cancer. 2008;113:1850-1856. [PMID: 18798546 DOI: 10.1002/cncr.23650] [Cited by in Crossref: 60] [Cited by in F6Publishing: 64] [Article Influence: 4.0] [Reference Citation Analysis]
199 Hipp S, Walch A, Schuster T, Losko S, Laux H, Bolton T, Höfler H, Becker KF. Activation of epidermal growth factor receptor results in snail protein but not mRNA overexpression in endometrial cancer. J Cell Mol Med 2009;13:3858-67. [PMID: 19604315 DOI: 10.1111/j.1582-4934.2008.00526.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
200 Segditsas S, Sieber OM, Rowan A, Setien F, Neale K, Phillips RK, Ward R, Esteller M, Tomlinson IP. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations. Exp Mol Pathol. 2008;85:201-206. [PMID: 18977219 DOI: 10.1016/j.yexmp.2008.09.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
201 Liu YN, Liu Y, Lee HJ, Hsu YH, Chen JH. Activated androgen receptor downregulates E-cadherin gene expression and promotes tumor metastasis. Mol Cell Biol 2008;28:7096-108. [PMID: 18794357 DOI: 10.1128/MCB.00449-08] [Cited by in Crossref: 86] [Cited by in F6Publishing: 95] [Article Influence: 5.7] [Reference Citation Analysis]
202 Chan TA, Glockner S, Yi JM, Chen W, Van Neste L, Cope L, Herman JG, Velculescu V, Schuebel KE, Ahuja N. Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med. 2008;5:e114. [PMID: 18507500 DOI: 10.1371/journal.pmed.0050114] [Cited by in Crossref: 110] [Cited by in F6Publishing: 117] [Article Influence: 7.3] [Reference Citation Analysis]
203 Kim HC, Lee HJ, Roh SA, Kim JS, Yu CS, Kim JC. CpG island methylation in familial colorectal cancer patients not fulfilling the Amsterdam criteria. J Korean Med Sci 2008;23:270-7. [PMID: 18437011 DOI: 10.3346/jkms.2008.23.2.270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
204 Cisco RM, Norton JA. Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions. Future Oncology 2008;4:553-9. [DOI: 10.2217/14796694.4.4.553] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
205 Kim SK, Jang HR, Kim JH, Kim M, Noh SM, Song KS, Kang GH, Kim HJ, Kim SY, Yoo HS, Kim YS. CpG methylation in exon 1 of transcription factor 4 increases with age in normal gastric mucosa and is associated with gene silencing in intestinal-type gastric cancers. Carcinogenesis 2008;29:1623-31. [PMID: 18635522 DOI: 10.1093/carcin/bgn110] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 1.7] [Reference Citation Analysis]
206 Schrader KA, Masciari S, Boyd N, Wiyrick S, Kaurah P, Senz J, Burke W, Lynch HT, Garber JE, Huntsman DG. Hereditary diffuse gastric cancer: association with lobular breast cancer. Fam Cancer 2008;7:73-82. [PMID: 18046629 DOI: 10.1007/s10689-007-9172-6] [Cited by in Crossref: 95] [Cited by in F6Publishing: 98] [Article Influence: 6.3] [Reference Citation Analysis]
207 Rojas A, Meherem S, Kim YH, Washington MK, Willis JE, Markowitz SD, Grady WM. The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer. Int J Cancer 2008;123:14-21. [PMID: 18425817 DOI: 10.1002/ijc.23608] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
208 Humar B, Guilford P. Hereditary diffuse gastric cancer and lost cell polarity: a short path to cancer. Future Oncol. 2008;4:229-239. [PMID: 18407736 DOI: 10.2217/14796694.4.2.229] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
209 Hipp S, Walch A, Schuster T, Höfler H, Becker KF. Precise measurement of the E-cadherin repressor Snail in formalin-fixed endometrial carcinoma using protein lysate microarrays. Clin Exp Metastasis 2008;25:679-83. [PMID: 18307046 DOI: 10.1007/s10585-008-9149-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
210 Hewitt KM, Sharma PK, Samowitz W, Hobbs M. Aberrant methylation of the HRPT2 gene in parathyroid carcinoma. Ann Otol Rhinol Laryngol 2007;116:928-33. [PMID: 18217513 DOI: 10.1177/000348940711601210] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
211 Robertson EV, Jankowski JA. Genetics of gastroesophageal cancer: paradigms, paradoxes, and prognostic utility. Am J Gastroenterol 2008;103:443-9. [PMID: 17925001 DOI: 10.1111/j.1572-0241.2007.01574.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
212 Grønbaek K, Hother C, Jones PA. Epigenetic changes in cancer. APMIS 2007;115:1039-59. [PMID: 18042143 DOI: 10.1111/j.1600-0463.2007.apm_636.xml.x] [Cited by in Crossref: 253] [Cited by in F6Publishing: 264] [Article Influence: 16.9] [Reference Citation Analysis]
213 Spellman PT, Costello JF, Gray JW. Cancer Genomics. The Molecular Basis of Cancer 2008. [DOI: 10.1016/b978-141603703-3.10020-2] [Reference Citation Analysis]
214 Pedrazzani C, Corso G, Marrelli D, Roviello F. E-cadherin and hereditary diffuse gastric cancer. Surgery. 2007;142:645-657. [PMID: 17981184 DOI: 10.1016/j.surg.2007.06.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
215 Guilford P, Blair V, More H, Humar B. A short guide to hereditary diffuse gastric cancer. Hered Cancer Clin Pract 2007;5:183-94. [PMID: 19725995 DOI: 10.1186/1897-4287-5-4-183] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
216 Yang S, Du J, Wang Z, Yuan W, Qiao Y, Zhang M, Zhang J, Gao S, Yin J, Sun B, Zhu T. BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells. BMC Cancer 2007;7:211. [PMID: 17997862 DOI: 10.1186/1471-2407-7-211] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 3.3] [Reference Citation Analysis]
217 Brena RM, Costello JF. Genome-epigenome interactions in cancer. Hum Mol Genet. 2007;16 Spec No 1:R96-105. [PMID: 17613554 DOI: 10.1093/hmg/ddm073] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
218 Schott M, Sagert C, Willenberg HS, Schinner S, Ramp U, Varro A, Raffel A, Eisenberger C, Zacharowski K, Perren A, Scherbaum WA. Carcinogenic Hypergastrinemia: Signet-Ring Cell Carcinoma in a Patient with Multiple Endocrine Neoplasia Type 1 with Zollinger-Ellison’s Syndrome. The Journal of Clinical Endocrinology & Metabolism 2007;92:3378-82. [DOI: 10.1210/jc.2007-0283] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
219 Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel MJ, Harris LN, Pinheiro HC, Troussard A, Miron P, Tung N, Oliveira C, Collins L, Schnitt S, Garber JE, Huntsman D. Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet. 2007;44:726-731. [PMID: 17660459 DOI: 10.1136/jmg.2007.051268] [Cited by in Crossref: 135] [Cited by in F6Publishing: 141] [Article Influence: 8.4] [Reference Citation Analysis]
220 Gylling A, Abdel-Rahman WM, Juhola M, Nuorva K, Hautala E, Järvinen HJ, Mecklin JP, Aarnio M, Peltomäki P. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study. Gut 2007;56:926-33. [PMID: 17267619 DOI: 10.1136/gut.2006.114876] [Cited by in Crossref: 73] [Cited by in F6Publishing: 79] [Article Influence: 4.6] [Reference Citation Analysis]
221 Castro Alves C, Rosivatz E, Schott C, Hollweck R, Becker I, Sarbia M, Carneiro F, Becker KF. Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol. 2007;211:507-515. [PMID: 17299729 DOI: 10.1002/path.2138] [Cited by in Crossref: 116] [Cited by in F6Publishing: 130] [Article Influence: 7.3] [Reference Citation Analysis]
222 Kaz A, Kim YH, Dzieciatkowski S, Lynch H, Watson P, Kay Washington M, Lin L, Grady WM. Evidence for the role of aberrant DNA methylation in the pathogenesis of Lynch syndrome adenomas. Int J Cancer 2007;120:1922-9. [PMID: 17278092 DOI: 10.1002/ijc.22544] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
223 Corso G, Roviello F, Paredes J, Pedrazzani C, Novais M, Correia J, Marrelli D, Cirnes L, Seruca R, Oliveira C. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management. Eur J Surg Oncol. 2007;33:1061-1067. [PMID: 17434710 DOI: 10.1016/j.ejso.2007.03.001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
224 Sezeur A, Schielke A, Larue L, Fléjou JF. [Hereditary diffuse gastric cancer]. Gastroenterol Clin Biol 2006;30:1205-13. [PMID: 17075480 DOI: 10.1016/s0399-8320(06)73513-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
225 Recillas-Targa F, De La Rosa-Velázquez IA, Soto-Reyes E, Benítez-Bribiesca L. Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis. J Cell Mol Med 2006;10:554-68. [PMID: 16989720 DOI: 10.1111/j.1582-4934.2006.tb00420.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
226 Rodriguez-sanjuan J, Fontalba A, Mayorga M, Bordin M, Hyland S, Trugeda S, Garcia R, Gomez-fleitas M, Fernandez F, Caldas C, Fernandez-luna J. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain. European Journal of Surgical Oncology (EJSO) 2006;32:1110-3. [DOI: 10.1016/j.ejso.2006.06.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
227 Carneiro F, Chaves P. Pathologic Risk Factors of Adenocarcinoma of the Gastric Cardia and Gastroesophageal Junction. Surgical Oncology Clinics of North America 2006;15:697-714. [DOI: 10.1016/j.soc.2006.07.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
228 Mikata R, Yokosuka O, Fukai K, Imazeki F, Arai M, Tada M, Kurihara T, Zhang K, Kanda T, Saisho H. Analysis of genes upregulated by the demethylating agent 5-aza-2'-deoxycytidine in gastric cancer cell lines. Int J Cancer 2006;119:1616-22. [PMID: 16671088 DOI: 10.1002/ijc.21968] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
229 Kim YH, Petko Z, Dzieciatkowski S, Lin L, Ghiassi M, Stain S, Chapman WC, Washington MK, Willis J, Markowitz SD, Grady WM. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 2006;45:781-9. [PMID: 16708352 DOI: 10.1002/gcc.20341] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 4.9] [Reference Citation Analysis]
230 Chan AO, Huang C, Hui WM, Cho CH, Yuen MF, Lam SK, Rashid A, Wong BC. Stability of E-cadherin methylation status in gastric mucosa associated with histology changes. Aliment Pharmacol Ther 2006;24:831-6. [PMID: 16918887 DOI: 10.1111/j.1365-2036.2006.03032.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
231 Feltus FA, Lee EK, Costello JF, Plass C, Vertino PM. DNA motifs associated with aberrant CpG island methylation. Genomics 2006;87:572-9. [DOI: 10.1016/j.ygeno.2005.12.016] [Cited by in Crossref: 77] [Cited by in F6Publishing: 82] [Article Influence: 4.5] [Reference Citation Analysis]
232 Liu YC, Shen CY, Wu HS, Hsieh TY, Chan DC, Chen CJ, Yu JC, Yu CP, Harn HJ, Chen PJ, Hsieh CB, Chen TW, Hsu HM. Mechanisms inactivating the gene for E-cadherin in sporadic gastric carcinomas. World J Gastroenterol 2006; 12(14): 2168-2173 [PMID: 16610016 DOI: 10.3748/wjg.v12.i14.2168] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 25] [Article Influence: 1.3] [Reference Citation Analysis]
233 Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol. 2006;14:21-33. [PMID: 16501831 DOI: 10.1177/106689690601400105] [Cited by in Crossref: 97] [Cited by in F6Publishing: 113] [Article Influence: 5.7] [Reference Citation Analysis]
234 Zhao CH, Zhang N, Bu XM, Li Y, Zhang HP. Multiple genes methylation detection in gastric cancer. Shijie Huaren Xiaohua Zazhi 2006; 14(10): 1004-1007 [DOI: 10.11569/wcjd.v14.i10.1004] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
235 Lombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, van Eijk R, Eilers PH, van de Water B, Cornelisse CJ. E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br J Cancer. 2006;94:661-671. [PMID: 16495925 DOI: 10.1038/sj.bjc.6602996] [Cited by in Crossref: 252] [Cited by in F6Publishing: 267] [Article Influence: 14.8] [Reference Citation Analysis]
236 Chan AO, Peng JZ, Lam SK, Lai KC, Yuen MF, Cheung HK, Kwong YL, Rashid A, Chan CK, Wong BC. Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation. Gut 2006;55:463-8. [PMID: 16428266 DOI: 10.1136/gut.2005.077776] [Cited by in Crossref: 132] [Cited by in F6Publishing: 125] [Article Influence: 7.8] [Reference Citation Analysis]
237 Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol. 2005;2 Suppl 1:S4-11. [PMID: 16341240 DOI: 10.1038/ncponc0354] [Cited by in Crossref: 795] [Cited by in F6Publishing: 849] [Article Influence: 46.8] [Reference Citation Analysis]
238 Zazula M, Ferreira AM, Czopek JP, Kolodziejczyk P, Sinczak-kuta A, Klimkowska A, Wojcik P, Okon K, Bialas M, Kulig J, Stachura J. CDH1 Gene Promoter Hypermethylation in Gastric Cancer: Relationship to Goseki Grading, Microsatellite Instability Status, and EBV Invasion. Diagnostic Molecular Pathology 2006;15:24-9. [DOI: 10.1097/00019606-200603000-00004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
239 Yu EY, Hahn WC. The Origin of Cancer. Cancer Treatment and Research. [DOI: 10.1007/1-4020-8107-3_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
240 Chan AOO. E-cadherin in gastric cancer. World J Gastroenterol 2006; 12(2): 199-203 [PMID: 16482618 DOI: 10.3748/wjg.v12.i2.199] [Cited by in CrossRef: 79] [Cited by in F6Publishing: 83] [Article Influence: 4.6] [Reference Citation Analysis]
241 Liu YN, Lee WW, Wang CY, Chao TH, Chen Y, Chen JH. Regulatory mechanisms controlling human E-cadherin gene expression. Oncogene. 2005;24:8277-8290. [PMID: 16116478 DOI: 10.1038/sj.onc.1208991] [Cited by in Crossref: 144] [Cited by in F6Publishing: 156] [Article Influence: 8.5] [Reference Citation Analysis]
242 Entrepreneurs and Start-Ups. Biocapital 2006. [DOI: 10.1215/9780822388005-007] [Reference Citation Analysis]
243 Vision and Hype. Biocapital 2006. [DOI: 10.1215/9780822388005-004] [Reference Citation Analysis]
244 Salvation and Nation. Biocapital 2006. [DOI: 10.1215/9780822388005-006] [Reference Citation Analysis]
245 References. Biocapital 2006. [DOI: 10.1215/9780822388005-009] [Reference Citation Analysis]
246 Barber M, Fitzgerald RC, Caldas C. Familial gastric cancer - aetiology and pathogenesis. Best Pract Res Clin Gastroenterol 2006;20:721-34. [PMID: 16997156 DOI: 10.1016/j.bpg.2006.03.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 1.8] [Reference Citation Analysis]
247 Introduction. Biocapital 2006. [DOI: 10.1215/9780822388005-001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
248 Fitzgerald RC, Caldas C. Familial gastric cancer - clinical management. Best Pract Res Clin Gastroenterol 2006;20:735-43. [PMID: 16997157 DOI: 10.1016/j.bpg.2006.03.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
249 Notes. Biocapital 2006. [DOI: 10.1215/9780822388005-008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
250 Exchange and Value. Biocapital 2006. [DOI: 10.1215/9780822388005-002] [Reference Citation Analysis]
251 Promise and Fetish. Biocapital 2006. [DOI: 10.1215/9780822388005-005] [Reference Citation Analysis]
252 Life and Debt. Biocapital 2006. [DOI: 10.1215/9780822388005-003] [Reference Citation Analysis]
253 Grady WM. Epigenetic events in the colorectum and in colon cancer. Biochem Soc Trans 2005;33:684-8. [PMID: 16042574 DOI: 10.1042/BST0330684] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 3.3] [Reference Citation Analysis]
254 Hsieh Y, Chang C, Tsai F, Hsu C, Lin C, Tsai C. The cuttable C-related genotype and allele for the E-cadherin 3’-UTR Pml I polymorphism are associated with higher susceptibility to endometriosis. Genet Mol Biol 2005;28:661-4. [DOI: 10.1590/s1415-47572005000500003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
255 Toyota M, Issa JP. Epigenetic changes in solid and hematopoietic tumors. Semin Oncol 2005;32:521-30. [PMID: 16210093 DOI: 10.1053/j.seminoncol.2005.07.003] [Cited by in Crossref: 94] [Cited by in F6Publishing: 99] [Article Influence: 5.2] [Reference Citation Analysis]
256 Chan AO, Chu KM, Lam SK, Cheung KL, Law S, Kwok KF, Wong WM, Yuen MF, Wong BC. Early prediction of tumor recurrence after curative resection of gastric carcinoma by measuring soluble E-cadherin. Cancer. 2005;104:740-746. [PMID: 15991243 DOI: 10.1002/cncr.21260] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
257 Stock M, Otto F. Gene deregulation in gastric cancer. Gene. 2005;360:1-19. [PMID: 16154715 DOI: 10.1016/j.gene.2005.06.026] [Cited by in Crossref: 79] [Cited by in F6Publishing: 93] [Article Influence: 4.4] [Reference Citation Analysis]
258 Kuphal S, Bosserhoff AK. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma. Oncogene 2006;25:248-59. [DOI: 10.1038/sj.onc.1209054] [Cited by in Crossref: 67] [Cited by in F6Publishing: 76] [Article Influence: 3.7] [Reference Citation Analysis]
259 Lynch HT, Grady W, Suriano G, Huntsman D. Gastric cancer: new genetic developments. J Surg Oncol. 2005;90:114-133; discussion 133. [PMID: 15895459 DOI: 10.1002/jso.20214] [Cited by in Crossref: 138] [Cited by in F6Publishing: 152] [Article Influence: 7.7] [Reference Citation Analysis]
260 Mccabe DC, Caudill MA. DNA Methylation, Genomic Silencing, and Links to Nutrition and Cancer. Nutrition Reviews 2005;63:183-95. [DOI: 10.1111/j.1753-4887.2005.tb00136.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 2.9] [Reference Citation Analysis]
261 Frebourg T, Oliveira C, Hochain P, Karam R, Manouvrier S, Graziadio C, Vekemans M, Hartmann A, Baert-Desurmont S, Alexandre C. Cleft lip/palate and CDH1/E-cadherin mutations in families with hereditary diffuse gastric cancer. J Med Genet. 2006;43:138-142. [PMID: 15831593 DOI: 10.1136/jmg.2005.031385] [Cited by in Crossref: 126] [Cited by in F6Publishing: 137] [Article Influence: 7.0] [Reference Citation Analysis]
262 Marshall BJ, Windsor HM. The relation of Helicobacter pylori to gastric adenocarcinoma and lymphoma: pathophysiology, epidemiology, screening, clinical presentation, treatment, and prevention. Med Clin North Am. 2005;89:313-344, viii. [PMID: 15656929 DOI: 10.1016/j.mcna.2004.09.001] [Cited by in Crossref: 96] [Cited by in F6Publishing: 106] [Article Influence: 5.3] [Reference Citation Analysis]
263 Yang Z, Zhang H, Kumar R. Regulation of E-cadherin. Breast Cancer Online 2005;8. [DOI: 10.1017/s1470903105003159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
264 Karpinets TV, Foy BD. Tumorigenesis: the adaptation of mammalian cells to sustained stress environment by epigenetic alterations and succeeding matched mutations. Carcinogenesis 2005;26:1323-34. [DOI: 10.1093/carcin/bgi079] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 3.1] [Reference Citation Analysis]
265 Nakamura E, Sugihara H, Bamba M, Hattori T. Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas. J Pathol. 2005;205:349-358. [PMID: 15682444 DOI: 10.1002/path.1718] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 1.2] [Reference Citation Analysis]
266 Ku JL, Park JG. Biology of SNU cell lines. Cancer Res Treat 2005;37:1-19. [PMID: 19956504 DOI: 10.4143/crt.2005.37.1.1] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 4.6] [Reference Citation Analysis]
267 Matsubayashi H, Sato N, Brune K, Blackford AL, Hruban RH, Canto M, Yeo CJ, Goggins M. Age- and Disease-Related Methylation of Multiple Genes in Nonneoplastic Duodenum and in Duodenal Juice. Clinical Cancer Research 2005;11:573-583. [DOI: 10.1158/1078-0432.573.11.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
268 Lu Y, Xu YC, Shen J, Yu RB, Niu JY, Guo JT, Hu X, Shen HB. E-cadherin gene C-160A promoter polymorphism and risk of non-cardia gastric cancer in a Chinese population. World J Gastroenterol 2005; 11(1): 56-60 [PMID: 15609397 DOI: 10.3748/wjg.v11.i1.56] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
269 Hayat M. 1 Gastrointestinal Carcinoma: An Introduction. Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma 2005. [DOI: 10.1016/s1874-5784(05)80063-7] [Reference Citation Analysis]
270 Luber B, Gamboa-dominguez A, Becker K, Fend F, Höfler H. 11 Role of Immunohistochemical Expression of E-Cadherin in Diffuse-Type Gastric Cancer. Molecular Genetics, Gastrointestinal Carcinoma, and Ovarian Carcinoma 2005. [DOI: 10.1016/s1874-5784(05)80073-x] [Reference Citation Analysis]
271 Van Marck VL, Bracke ME. Epithelial-Mesenchymal Transitions in Human Cancer. Rise and Fall of Epithelial Phenotype 2005. [DOI: 10.1007/0-387-28671-3_9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
272 Berx G, Van Roy F. Epithelial Cell Plasticity by Dynamic Transcriptional Regulation of E-Cadherin. Rise and Fall of Epithelial Phenotype 2005. [DOI: 10.1007/0-387-28671-3_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
273 Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N, Butterfield YS, Jeyes J, Schinas J, Bacani J, Kelsey M, Ferreira P, MacGillivray B, MacLeod P, Micek M, Ford J, Foulkes W, Australie K, Greenberg C, LaPointe M, Gilpin C, Nikkel S, Gilchrist D, Hughes R, Jackson CE, Monaghan KG, Oliveira MJ, Seruca R, Gallinger S, Caldas C, Huntsman D. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet. 2004;41:508-517. [PMID: 15235021 DOI: 10.1136/jmg.2004.018275] [Cited by in Crossref: 265] [Cited by in F6Publishing: 292] [Article Influence: 13.9] [Reference Citation Analysis]
274 Hanna N. Hereditary Diffuse Gastric Cancer Syndrome. Encyclopedia of Medical Genomics and Proteomics 2004. [DOI: 10.3109/9780203997352.122] [Reference Citation Analysis]
275 Rashid A, Issa JP. CpG island methylation in gastroenterologic neoplasia: a maturing field. Gastroenterology 2004;127:1578-88. [PMID: 15521024 DOI: 10.1053/j.gastro.2004.09.007] [Cited by in Crossref: 106] [Cited by in F6Publishing: 110] [Article Influence: 5.6] [Reference Citation Analysis]
276 Concolino P, Papa V, Mozzetti S, Ferlini C, Pacelli F, Martinelli E, Ricci R, Filippetti F, Scambia G, Doglietto GB. The unsolved enigma of CDH1 down-regulation in hereditary diffuse gastric cancer. J Surg Res. 2004;121:50-55. [PMID: 15313375 DOI: 10.1016/j.jss.2004.03.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
277 Yu J, Zhang H, Gu J, Lin S, Li J, Lu W, Wang Y, Zhu J. Methylation profiles of thirty four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma. BMC Cancer. 2004;4:65. [PMID: 15367334 DOI: 10.1186/1471-2407-4-65] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 5.0] [Reference Citation Analysis]
278 Lombaerts M, Middeldorp JW, van der Weide E, Philippo K, van Wezel T, Smit VT, Cornelisse CJ, Cleton-Jansen AM. Infiltrating leukocytes confound the detection of E-cadherin promoter methylation in tumors. Biochem Biophys Res Commun. 2004;319:697-704. [PMID: 15178462 DOI: 10.1016/j.bbrc.2004.05.041] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
279 Graziano F, Arduini F, Ruzzo A, Mandolesi A, Bearzi I, Silva R, Muretto P, Testa E, Mari D, Magnani M. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs. Ann Oncol. 2004;15:489-492. [PMID: 14998854 DOI: 10.1093/annonc/mdh108] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.1] [Reference Citation Analysis]
280 Gopalakrishna Iyer N, Caldas C. Gastric Cancer — Keeping It in the Family. Cancer Rev A P 2004;02:69-79. [DOI: 10.1142/s021983630400038x] [Reference Citation Analysis]
281 Kim TY, Jong HS, Jung Y, Kim TY, Kang GH, Bang YJ. DNA hypermethylation in gastric cancer. Aliment Pharmacol Ther 2004;20 Suppl 1:131-42. [PMID: 15298619 DOI: 10.1111/j.1365-2036.2004.01984.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 1.5] [Reference Citation Analysis]
282 Yao X, Hu JF, Li T, Yang Y, Sun Z, Ulaner GA, Vu TH, Hoffman AR. Epigenetic regulation of the taxol resistance-associated gene TRAG-3 in human tumors. Cancer Genet Cytogenet 2004;151:1-13. [PMID: 15120907 DOI: 10.1016/j.cancergencyto.2003.08.021] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.2] [Reference Citation Analysis]
283 Charlton A, Blair V, Shaw D, Parry S, Guilford P, Martin IG. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 2004;53:814-20. [PMID: 15138207 DOI: 10.1136/gut.2002.010447] [Cited by in Crossref: 135] [Cited by in F6Publishing: 128] [Article Influence: 7.1] [Reference Citation Analysis]
284 Fitzgerald RC, Caldas C. Clinical implications of E-cadherin associated hereditary diffuse gastric cancer. Gut 2004;53:775-8. [PMID: 15138199 DOI: 10.1136/gut.2003.022061] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 3.6] [Reference Citation Analysis]
285 Charlton A, Blair V, Shaw D, Parry S, Guilford P, Martin IG. Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut 2004;53:814-20. [PMID: 15138207 DOI: 10.1136/gut.2002.010447] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
286 Oliveira C, Suriano G, Ferreira P, Canedo P, Kaurah P, Mateus R, Ferreira A, Ferreira AC, Oliveira MJ, Figueiredo C, Carneiro F, Keller G, Huntsman D, Machado JC, Seruca R. Genetic screening for familial gastric cancer. Hered Cancer Clin Pract 2004;2:51-64. [PMID: 20233471 DOI: 10.1186/1897-4287-2-2-51] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 1.1] [Reference Citation Analysis]
287 Graziano F, Humar B, Guilford P. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol. 2003;14:1705-1713. [PMID: 14630673 DOI: 10.1093/annonc/mdg486] [Cited by in Crossref: 102] [Cited by in F6Publishing: 106] [Article Influence: 5.4] [Reference Citation Analysis]
288 Peng DF, Sugihara H, Mukaisho K, Tsubosa Y, Hattori T. Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours. J Pathol. 2003;201:439-450. [PMID: 14595756 DOI: 10.1002/path.1459] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 3.3] [Reference Citation Analysis]
289 Strumane K, Berx G, Van Roy F. Cadherins in cancer. Handb Exp Pharmacol 2004;:69-103. [PMID: 20455091 DOI: 10.1007/978-3-540-68170-0_4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 1.5] [Reference Citation Analysis]
290 van Noesel MM, van Bezouw S, Voûte PA, Herman JG, Pieters R, Versteeg R. Clustering of hypermethylated genes in neuroblastoma. Genes Chromosomes Cancer 2003;38:226-33. [PMID: 14506696 DOI: 10.1002/gcc.10278] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 3.1] [Reference Citation Analysis]
291 El-osta A. DNMT cooperativity?the developing links between methylation, chromatin structure and cancer. Bioessays 2003;25:1071-84. [DOI: 10.1002/bies.10345] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 2.9] [Reference Citation Analysis]
292 Cross S, Bury J. Molecular biology in diagnostic histopathology: Part II — cell adhesion molecules. Current Diagnostic Pathology 2003;9:313-21. [DOI: 10.1016/s0968-6053(03)00054-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
293 Semczuk A, Boltze C, Marzec B, Szczygielska A, Roessner A, Schneider-Stock R. p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas. J Cancer Res Clin Oncol 2003;129:589-96. [PMID: 12920579 DOI: 10.1007/s00432-003-0482-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 1.3] [Reference Citation Analysis]
294 Chan AO, Chu KM, Lam SK, Wong BC, Kwok KF, Law S, Ko S, Hui WM, Yueng YH, Wong J. Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer. J Clin Oncol. 2003;21:2288-2293. [PMID: 12805328 DOI: 10.1200/jco.2003.08.078] [Cited by in Crossref: 52] [Cited by in F6Publishing: 58] [Article Influence: 2.6] [Reference Citation Analysis]
295 Bamforth F, Brown L, Senz J, Huntsman D. Mechanisms of monozygotic (MZ) twinning: A possible role for the cell adhesion molecule, E-cadherin. Am J Med Genet 2003;120A:59-62. [DOI: 10.1002/ajmg.a.20076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
296 Mareel M, Leroy A. Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev. 2003;83:337-376. [PMID: 12663862 DOI: 10.1152/physrev.00024.2002] [Cited by in Crossref: 345] [Cited by in F6Publishing: 364] [Article Influence: 17.3] [Reference Citation Analysis]
297 Tsuiji H, Takasaki S, Sakamoto M, Irimura T, Hirohashi S. Aberrant O-glycosylation inhibits stable expression of dysadherin, a carcinoma-associated antigen, and facilitates cell-cell adhesion. Glycobiology 2003;13:521-7. [PMID: 12672699 DOI: 10.1093/glycob/cwg065] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 2.4] [Reference Citation Analysis]
298 Chan AO, Lam SK, Wong BC, Wong WM, Yuen MF, Yeung YH, Hui WM, Rashid A, Kwong YL. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut 2003;52:502-6. [PMID: 12631658 DOI: 10.1136/gut.52.4.502] [Cited by in Crossref: 208] [Cited by in F6Publishing: 199] [Article Influence: 10.4] [Reference Citation Analysis]
299 Nephew KP, Huang TH. Epigenetic gene silencing in cancer initiation and progression. Cancer Lett. 2003;190:125-133. [PMID: 12565166 DOI: 10.1016/s0304-3835(02)00511-6] [Cited by in Crossref: 126] [Cited by in F6Publishing: 109] [Article Influence: 6.3] [Reference Citation Analysis]
300 Strathdee G. Epigenetic versus genetic alterations in the inactivation of E-cadherin. Semin Cancer Biol. 2002;12:373-379. [PMID: 12191636 DOI: 10.1016/s1044-579x(02)00057-3] [Cited by in Crossref: 140] [Cited by in F6Publishing: 112] [Article Influence: 7.0] [Reference Citation Analysis]
301 Garinis GA, Menounos PG, Spanakis NE, Papadopoulos K, Karavitis G, Parassi I, Christeli E, Patrinos GP, Manolis EN, Peros G. Hypermethylation-associated transcriptional silencing of E-cadherin in primary sporadic colorectal carcinomas. J Pathol. 2002;198:442-449. [PMID: 12434413 DOI: 10.1002/path.1237] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
302 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(1): 65-71 [DOI: 10.11569/wcjd.v11.i1.65] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
303 Schneider-Stock R, Giers A, Motsch C, Boltze C, Evert M, Freigang B, Roessner A. Hereditary p16-Leiden mutation in a patient with multiple head and neck tumors. Am J Hum Genet 2003;72:216-8. [PMID: 12549483 DOI: 10.1086/345397] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
304 Ohlsson R, Kanduri C, Whitehead J, Pfeifer S, Lobanenkov V, Feinberg AP. Epigenetic variability and the evolution of human cancer. Elsevier; 2003. pp. 145-68. [DOI: 10.1016/s0065-230x(03)88306-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
305 Sobrinho-Simões M, Oliveira C. Different types of epithelial cadherin alterations play different roles in human carcinogenesis. Adv Anat Pathol 2002;9:329-37. [PMID: 12409641 DOI: 10.1097/00125480-200211000-00001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
306 Jass JR, Whitehall VL, Young J, Leggett BA. Emerging concepts in colorectal neoplasia. Gastroenterology 2002;123:862-76. [PMID: 12198712 DOI: 10.1053/gast.2002.35392] [Cited by in Crossref: 333] [Cited by in F6Publishing: 362] [Article Influence: 15.9] [Reference Citation Analysis]
307 Smiraglia DJ, Plass C. The study of aberrant methylation in cancer via restriction landmark genomic scanning. Oncogene 2002;21:5414-26. [PMID: 12154404 DOI: 10.1038/sj.onc.1205608] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 2.5] [Reference Citation Analysis]
308 Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3:415-28. [DOI: 10.1038/nrg816] [Cited by in Crossref: 3344] [Cited by in F6Publishing: 3824] [Article Influence: 159.2] [Reference Citation Analysis]
309 Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002;109:987-91. [PMID: 11956233 DOI: 10.1172/JCI15429] [Cited by in Crossref: 9] [Cited by in F6Publishing: 179] [Article Influence: 0.4] [Reference Citation Analysis]
310 Conacci-Sorrell M, Zhurinsky J, Ben-Ze’ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest. 2002;109:987-991. [PMID: 11956233 DOI: 10.1172/jci200215429] [Cited by in Crossref: 71] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
311 Conacci-Sorrell M, Zhurinsky J, Ben-Ze’ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest. 2002;109:987-991. [PMID: 11956233 DOI: 10.1172/jci0215429] [Cited by in Crossref: 409] [Cited by in F6Publishing: 405] [Article Influence: 19.5] [Reference Citation Analysis]
312 Jonsson BA, Bergh A, Stattin P, Emmanuelsson M, Grönberg H. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer. Int J Cancer 2002;98:838-43. [PMID: 11948460 DOI: 10.1002/ijc.10258] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 1.9] [Reference Citation Analysis]
313 Baylin S, Bestor TH. Altered methylation patterns in cancer cell genomes: Cause or consequence? Cancer Cell 2002;1:299-305. [DOI: 10.1016/s1535-6108(02)00061-2] [Cited by in Crossref: 215] [Cited by in F6Publishing: 232] [Article Influence: 10.2] [Reference Citation Analysis]
314 El-rifai W, Powell SM. Molecular and biologic basis of upper gastrointestinal malignancy. Surgical Oncology Clinics of North America 2002;11:273-91. [DOI: 10.1016/s1055-3207(02)00004-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
315 Dunbier A, Guilford P. Hereditary diffuse gastric cancer. Adv Cancer Res 2001;83:55-65. [PMID: 11665720 DOI: 10.1016/s0065-230x(01)83002-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.3] [Reference Citation Analysis]
316 Mingchao TR, Stockton P, Sun K, Sills RC, Clayton N, Portier M, Flake G. Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis. Exp Toxicol Pathol. 2001;53:237-246. [PMID: 11665847 DOI: 10.1078/0940-2993-00190] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 0.7] [Reference Citation Analysis]
317 Li H, Myeroff L, Kasturi L, Krumroy L, Schwartz S, Willson JK, Stanbridge E, Casey G, Markowitz S. Chromosomal autonomy of hMLH1 methylation in colon cancer. Oncogene 2002;21:1443-9. [DOI: 10.1038/sj.onc.1205247] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
318 Dunbier AK, Guilford PJ. Gastric Cancer: Inherited Predisposition. Encyclopedia of Cancer 2002. [DOI: 10.1016/b0-12-227555-1/00091-5] [Reference Citation Analysis]
319 Shen L, Issa JP. Epigenetics in colorectal cancer. Curr Opin Gastroenterol 2002;18:68-73. [PMID: 17031233 DOI: 10.1097/00001574-200201000-00012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.1] [Reference Citation Analysis]
320 Devilee P, Cleton-Jansen AM, Cornelisse CJ. Ever since Knudson. Trends Genet 2001;17:569-73. [PMID: 11585662 DOI: 10.1016/s0168-9525(01)02416-7] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 3.4] [Reference Citation Analysis]
321 Pharoah PD, Guilford P, Caldas C; International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001;121:1348-53. [PMID: 11729114 DOI: 10.1053/gast.2001.29611] [Cited by in Crossref: 432] [Cited by in F6Publishing: 471] [Article Influence: 19.6] [Reference Citation Analysis]
322 Cleton-Jansen AM. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? Breast Cancer Res 2002;4:5-8. [PMID: 11879552 DOI: 10.1186/bcr416] [Cited by in Crossref: 88] [Cited by in F6Publishing: 93] [Article Influence: 4.0] [Reference Citation Analysis]
323 Costello JF, Plass C. Methylation matters. J Med Genet. 2001;38:285-303. [PMID: 11333864 DOI: 10.1136/jmg.38.5.285] [Cited by in Crossref: 378] [Cited by in F6Publishing: 406] [Article Influence: 17.2] [Reference Citation Analysis]
324 Ascaño JJ, Frierson H, Moskaluk CA, Harper JC, Roviello F, Jackson CE, El-rifai W, Vindigni C, Tosi P, Powell SM. Inactivation of the E-Cadherin Gene in Sporadic Diffuse-Type Gastric Cancer. Mod Pathol 2001;14:942-9. [DOI: 10.1038/modpathol.3880416] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 2.4] [Reference Citation Analysis]
325 Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW, Shen CY. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene. 2001;20:3814-3823. [PMID: 11439345 DOI: 10.1038/sj.onc.1204505] [Cited by in Crossref: 166] [Cited by in F6Publishing: 177] [Article Influence: 7.5] [Reference Citation Analysis]
326 Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res. 2001;3:289-293. [PMID: 11597316 DOI: 10.1186/bcr309] [Cited by in Crossref: 302] [Cited by in F6Publishing: 319] [Article Influence: 13.7] [Reference Citation Analysis]
327 Yang VW, Dubois RN. The molecular medicine of colorectal cancer. Trends in Molecular Medicine 2001;7:241-242. [DOI: 10.1016/s1471-4914(01)02036-6] [Reference Citation Analysis]
328 Tomlinson IP, Roylance R, Houlston RS. Two hits revisited again. J Med Genet 2001;38:81-5. [PMID: 11158170 DOI: 10.1136/jmg.38.2.81] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 1.5] [Reference Citation Analysis]
329 Machado JC, Oliveira C, Carvalho R, Soares P, Berx G, Caldas C, Seruca R, Carneiro F, Sobrinho-Simöes M. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 2001;20:1525-1528. [PMID: 11313896 DOI: 10.1038/sj.onc.1204234] [Cited by in Crossref: 192] [Cited by in F6Publishing: 213] [Article Influence: 8.7] [Reference Citation Analysis]
330 Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB, Issa JP. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 1999;59:5438-5442. [PMID: 10554013 DOI: 10.1016/j.canlet.2014.05.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
331 Peinado H, Cano A. Epigenetic Regulation of the E-Cadherin Cell-Cell Adhesion Gene. In: Esteller M, editor. DNA Methylation, Epigenetics and Metastasis. Berlin/Heidelberg: Springer-Verlag; 2005. pp. 157-90. [DOI: 10.1007/1-4020-3642-6_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]